Wenjing Wang
- Infectious Diseases top 5%
- Pharmacology top 5%
- Molecular Biology
- Neurology top 10%
- Biotechnology top 5%
- Topics
- Microbial Natural Products and Biosynthesis (12 papers)COVID-19 Clinical Research Studies (6 papers)Long-Term Effects of COVID-19 (6 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Wenjing Wang
42 papers receiving 790 citations
Peers
Comparison fields: 5 of 110
- Infectious Diseases 311
- Pharmacology 201
- Molecular Biology 165
- Neurology 153
- Biotechnology 98
Countries citing papers authored by Wenjing Wang
This map shows the geographic impact of Wenjing Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjing Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjing Wang more than expected).
Fields of papers citing papers by Wenjing Wang
This network shows the impact of papers produced by Wenjing Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjing Wang. The network helps show where Wenjing Wang may publish in the future.
Co-authorship network of co-authors of Wenjing Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Wenjing Wang. A scholar is included among the top collaborators of Wenjing Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjing Wang. Wenjing Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | 12 | |
| 7 | 7 | |
| 8 | 5 | |
| 9 | 16 | |
| 10 | 3 | |
| 11 | 28 | |
| 12 | 16 | |
| 13 | 99 | |
| 14 | 63 | |
| 15 | 1 | |
| 16 | 11 | |
| 17 | 37 | |
| 18 | 8 | |
| 19 | 1 | |
| 20 | 22 |
About Wenjing Wang
Wenjing Wang is a scholar working on Pharmacology, Biotechnology and Infectious Diseases, having authored 46 papers that have together received 799 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (12 papers), COVID-19 Clinical Research Studies (6 papers) and Long-Term Effects of COVID-19 (6 papers). The work is most often cited by research in Infectious Diseases (311 citations), Pharmacology (201 citations) and Biotechnology (98 citations). Wenjing Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Dexi Chen, Lijun Pang, Yingmei Feng, Chunmei Chen, Yabo Ouyang, Hongbo Shi, Luxin Qiao, Xianghua Guo, Hucheng Zhu and Ronghua Jin. Their work appears in journals such as Clinical Infectious Diseases, Scientific Reports and Environmental Pollution.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.